Robert Parks
CIK 1707662 · Chief Accounting Officer · last filed 2026-05-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
NTAP price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
8 MOORE DRIVE
DURHAM, NC 27709
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FTRE | Chief Accounting Officer | 20,389 | $24.24 | $494.2K | -$123.4K | 7 | 2026-05-20 |
| NTAP | Chief Accounting Officer | 0 | $228.06 | $0 | -$691.7K | 14 | 2023-08-30 |
| Syneos Health, Inc. (SYNH) Delisted | EVP, Chief Accounting Officer | 10,903 | $42.98 | $468.6K | -$178.1K | 7 | 2021-01-20 |
| IQV | Sr Vice President, Controller | 1,721 | $274.97 | $473.2K | -$203.0K | 4 | 2018-08-06 |
| Q | Sr Vice President, Controller | — | $116.93 | — | $0 | 1 | 2017-05-25 |
Recent Filings · Page 3 of 4
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-08-17 | NTAP | Mixed | +591 | $11.7K | EDGAR |
| 2022-07-06 | NTAP | Mixed | +326 | $19.9K | EDGAR |
| 2022-05-16 | NTAP | Mixed | +1,059 | -$31.4K | EDGAR |
| 2022-02-17 | NTAP | Mixed | +2,178 | -$88.8K | EDGAR |
| 2021-07-06 | NTAP | Grant (A) | — | $0 | EDGAR |
| 2021-02-19 | NTAP | Grant (A) | — | $0 | EDGAR |
| 2021-01-20 | Syneos Health, Inc. (SYNH) Delisted | Tax (F) | −405 | -$31.2K | EDGAR |
| 2021-01-11 | Syneos Health, Inc. (SYNH) Delisted | Tax (F) | −679 | -$50.0K | EDGAR |
| 2020-12-04 | Syneos Health, Inc. (SYNH) Delisted | Tax (F) | −660 | -$41.3K | EDGAR |
| 2020-04-21 | Syneos Health, Inc. (SYNH) Delisted | Mixed | −3,211 | -$161.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.